Mohammad Behnam

Mohammad Behnam

Auto-generated profile, based on publicly available information

Mohammad Behnam

Halal Research Center of IRI, FDA, Tehran, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
EKEbrahim Kouchaki
Ebrahim Kouchaki
RKReza Daneshvar Kakhaki
Reza Daneshvar Kakhaki
OTOmid Reza Tamtaji
Omid Reza Tamtaji
EDEhsan Dadgostar
Ehsan Dadgostar
MBMohammad Behnam
Mohammad Behnam
HAHossein Akbari
Hossein Akbari

24 May 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
OTOmid Reza Tamtaji
Omid Reza Tamtaji
MBMohammad Behnam
Mohammad Behnam
MPMohammad Ali Pourattar
Mohammad Ali Pourattar
HJHamed Jafarpour
Hamed Jafarpour
ZAZatollah Asemi
Zatollah Asemi

27 June 2019 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
OTOmid Reza Tamtaji
Omid Reza Tamtaji
HMHamed Mirzaei
Hamed Mirzaei
ASAmir Shamshirian
Amir Shamshirian
DSDanial Shamshirian
Danial Shamshirian
MBMohammad Behnam
Mohammad Behnam
ZAZatollah Asemi
Zatollah Asemi

13 August 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
EKEbrahim Kouchaki
Ebrahim Kouchaki
RKReza Daneshvar Kakhaki
Reza Daneshvar Kakhaki
OTOmid Reza Tamtaji
Omid Reza Tamtaji
EDEhsan Dadgostar
Ehsan Dadgostar
MBMohammad Behnam
Mohammad Behnam
ZAZatollah Asemi
Zatollah Asemi

1 May 2020 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
RKReza Daneshvar Kakhaki
Reza Daneshvar Kakhaki
EKEbrahim Kouchaki
Ebrahim Kouchaki
EDEhsan Dadgostar
Ehsan Dadgostar
MBMohammad Behnam
Mohammad Behnam
OTOmid Reza Tamtaji
Omid Reza Tamtaji
HAHossein Akbari
Hossein Akbari

13 May 2019 in Journal of Immunoassay and Immunochemistry
Verified
Journal Article
Closed access
EKEbrahim Kouchaki
Ebrahim Kouchaki
HNHassan Nikoueinejad
Hassan Nikoueinejad
HAHossein Akbari
Hossein Akbari
SAShirin Azimi
Shirin Azimi
MBMohammad Behnam
Mohammad Behnam
Introduction: PIAS1 and PIAS2 (protein inhibitor of activated STAT 1,2) play key roles in the pathogenesis of autoimmune and inflammatory diseases. This study aims to evaluate the gene expression of these factors in multiple sclerosis (MS) patients compared to healthy individuals and correlate them with the severity of MS. Materials and methods: Sixty participants, including 30 patients with MS and 30 healthy controls were studied. The expression of PIAS1 and PIAS2 genes in peripheral blood samples of all participants was measured by real-time PCR. The severity of MS was evaluated using the Expanded Disability Status Scale (EDSS). Finally, we evaluated the correlation between the expression of PIAS1 and PIAS2 genes with disease severity. Results: The expression of PIAS1 gene was increased in patients with MS compared to healthy subjects (P value<.001). Also, there was a significant correlation between the expression of PIAS1 and PIAS2 genes with disease severity according to EDSS. Conclusion: Our study suggests the expression of PIAS1 and PIAS2 genes as a prognostic and diagnostic marker in MS disease.